Rapid diagnostic technologies and portable devices are transforming infectious disease management in low-resource settings by enabling timely, accurate, and cost-effective diagnosis. These innovations address critical challenges in healthcare delivery, including limited access to diagnostic facilities, delays in diagnosis, and financial constraints. Rapid diagnostic tests (RDTs), such as lateral flow assays and molecular diagnostics, allow for quick identification of pathogens, enabling immediate treatment and reducing the spread of infectious diseases. Portable diagnostic devices, including handheld PCR machines and smartphone-based tools, enhance healthcare accessibility by providing diagnostic capabilities in remote and underserved areas. These technologies are user-friendly, require minimal training, and can operate in diverse environments without extensive infrastructure. They improve disease surveillance, facilitate timely interventions, and reduce the misuse of antibiotics, combating antibiotic resistance. Additionally, the integration of digital health technologies, such as mobile health (mHealth) applications and electronic health records (EHRs), enhances data collection and patient management. The benefits of these technologies extend beyond diagnosis, contributing to improved public health responses and disease control. Challenges in implementing these technologies include ensuring device compatibility, quality assurance, and sustainable funding. However, ongoing research and development are advancing diagnostic capabilities, with innovations in molecular diagnostics, AI integration, and portable device manufacturing. Continued investment in these technologies is essential for achieving global health equity and sustainable development. The integration of rapid diagnostic technologies and portable devices represents a transformative approach to healthcare, offering scalable solutions to enhance diagnostic capabilities and improve health outcomes worldwide.Rapid diagnostic technologies and portable devices are transforming infectious disease management in low-resource settings by enabling timely, accurate, and cost-effective diagnosis. These innovations address critical challenges in healthcare delivery, including limited access to diagnostic facilities, delays in diagnosis, and financial constraints. Rapid diagnostic tests (RDTs), such as lateral flow assays and molecular diagnostics, allow for quick identification of pathogens, enabling immediate treatment and reducing the spread of infectious diseases. Portable diagnostic devices, including handheld PCR machines and smartphone-based tools, enhance healthcare accessibility by providing diagnostic capabilities in remote and underserved areas. These technologies are user-friendly, require minimal training, and can operate in diverse environments without extensive infrastructure. They improve disease surveillance, facilitate timely interventions, and reduce the misuse of antibiotics, combating antibiotic resistance. Additionally, the integration of digital health technologies, such as mobile health (mHealth) applications and electronic health records (EHRs), enhances data collection and patient management. The benefits of these technologies extend beyond diagnosis, contributing to improved public health responses and disease control. Challenges in implementing these technologies include ensuring device compatibility, quality assurance, and sustainable funding. However, ongoing research and development are advancing diagnostic capabilities, with innovations in molecular diagnostics, AI integration, and portable device manufacturing. Continued investment in these technologies is essential for achieving global health equity and sustainable development. The integration of rapid diagnostic technologies and portable devices represents a transformative approach to healthcare, offering scalable solutions to enhance diagnostic capabilities and improve health outcomes worldwide.